An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder

NCT00358631 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
319
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi